APA Research Essay: Can Medication Cure Obesity In Children?
Running head: CAN MEDICATION CURE OBESITY IN CHILDREN?
The header consists of a shortened title in all capital letters at the left margin and the page number at the right margin; on the title page only, the shortened title is preceded by the words “Running head” and a colon.
Can Medication Cure Obesity in Children? A Review of the Literature Luisa Mirano Northwest-Shoals Community College
Full title, writer’s name, and school halfway down the page.
Author Note This paper was prepared for Psychology 108, Section B, taught by Professor Kang.
An author’s note lists the specific information about the course or department and can provide acknowledgments and contact information.
Marginal annotations indicate APA-style formatting and effective writing.
Source: Hacker/Sommers (Boston: Bedford/St. Martin’s, 2011, 2006). This paper follows the style guidelines in the Publication Manual of the American Psychological Association, 6th ed. (2010). 5/11_A
CAN MEDICATION CURE OBESITY IN CHILDREN? Abstract
In recent years, policymakers and medical experts have expressed alarm about the growing problem of childhood obesity in the
Abstract appears on a separate page. …show more content…
646). The study was not controlled against a placebo group; therefore, the relative effectiveness of orlistat in this case remains unclear. Is Medication Safe for Children? While modest weight loss has been documented for both medications, each carries risks of certain side effects. Sibutramine has been observed to increase blood pressure and pulse rate. In 2002, a consumer group claimed that the medication was related to the deaths of 19 people and filed a petition with the Department of Health and Human Services to ban the medication (Hilts, 2002). The sibutramine study by Berkowitz et al. (2003) noted elevated blood pressure as a side effect, and dosages had to be reduced or the medication discontinued in 19 of the 43 subjects in the first six months (p. 1809). The main side effects associated with orlistat were abdominal discomfort, oily spotting, fecal incontinence, and nausea (Roche Laboratories, 2003, p. 13). More serious for longterm health is the concern that orlistat, being a fat-blocker, would affect absorption of fat-soluble vitamins, such as vitamin D. However, the study found that this side effect can be minimized or eliminated if patients take vitamin supplements two hours before or after administration of orlistat (p. 10). With